SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Brooks Laboratories - Quaterly Results

31 Jan 2024 Evaluate
The Top line for the quarter ended December 2023 of Rs. 217.47 millions up 81.18% from Rs. 120.03 millions.The Total Profit for the quarter ended December 2023 of Rs. 5.77 millions grew from Rs.-20.81 millions Operating profit Margin for the quarter ended December 2023 improved to 12.51% as compared to -14.12% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 217.47 120.03 81.18 617.65 428.41 44.17 555.38 769.67 -27.84
Other Income 1.55 0.60 158.33 3.02 1.71 76.61 1.07 9.48 -88.71
PBIDT 12.51 -14.12 -188.60 31.38 -56.06 -155.98 -57.07 28.23 -302.16
Interest 2.13 2.40 -11.25 5.71 5.82 -1.89 7.67 6.70 14.48
PBDT 10.38 -16.52 -162.83 25.67 -61.88 -141.48 -64.74 21.53 -400.70
Depreciation 4.35 4.29 1.40 13.17 12.82 2.73 17.17 14.86 15.55
PBT 6.03 -20.81 -128.98 12.50 -74.70 -116.73 -81.91 6.67 -1328.04
TAX 0.26 0.00 0.00 0.26 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 5.77 -20.81 -127.73 12.24 -74.70 -116.39 -81.91 6.67 -1328.04
Equity 262.47 247.03 6.25 262.47 247.03 6.25 247.03 247.03 0.00
PBIDTM(%) 5.75 -11.76 -148.90 5.08 -13.09 -138.83 -10.28 3.67 -380.17

Brooks Laboratories Share Price

67.25 0.86 (1.30%)
15-Jun-2026 12:42 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1805.00
Dr. Reddys Lab 1282.00
Cipla 1382.90
Zydus Lifesciences 1092.00
Lupin 2275.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: